Global Subcutaneous Drug Delivery Devices Market Size study, by Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-Free Injectors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027

Global Subcutaneous Drug Delivery Devices Market is valued approximately at USD 9.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2020-2027. Subcutaneous drugs are vaccinated in the layer of the skin called the cutis, which includes dermis and epidermis. The subcutaneous parenteral route of drug delivery is operative for managing vaccines and for continual release drugs and for goserelin, insulin, etc. The subcutaneous drug delivery systems are generally utilized by the end-users owing to the easy and consistent operating mechanism. Several pharmaceutical products are promoted and being established for numerous diseases, which are managed through subcutaneous routes. Drug manufactures are also emphasizing on easy administration process of drug delivery, so as the drug can be extremely effective among the patients. Many pharmaceutical companies are evolving and developing self-managed drugs, the adoption rate of subcutaneous drug delivery devices has grown across the globe. Moreover, the rise in prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer etc., growing production of biologics, and rising emphasis on self-administration, prevention of needlestick injuries and dosing errors are the few factors responsible for the high CAGR of the market during the forecast period. According to the American Heart Association, cardiovascular diseases (CVD) is the leading cause of mortality and morbidity around the world. There were around 17.6 million deaths due to CVD reported in 2016, which is projected to reach almost 23.6 million by the year 2030. While as per the International Diabetic Federation (IDF), there were almost 463 million adults aged between 20-79 years are affected with diabetes in 2019, and this estimation is anticipated to reach at almost 700 million by the year 2045. This, in turn, is likely to strengthen the demand for subcutaneous drug delivery devices, thus accelerating the market growth around the world. However, the high cost of advanced delivery systems and lack of awareness about these devices are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Subcutaneous Drug Delivery Devices market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in prevalence of cancer and cardiovascular diseases, along with the presence of substantial number of suppliers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of diabetic and multiple sclerosis patients coupled with improving healthcare infrastructure in the developing nations, such as China and India, would create lucrative growth prospects for the Subcutaneous Drug Delivery Devices market across the Asia-Pacific region.

Major market player included in this report are:
Gerresheimer AG
Medtronic plc
Ypsomed AG
Elcam Medical Group
Novo Nordisk A/S
Insulet Corporation
Becton, Dickinson, and Company
West Pharmaceutical Services, Inc.
PharmaJet, Inc.
Unilife Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Prefilled Syringes
Pen Injectors
Auto Injectors
Wearable Injectors
Needle-Free Injectors

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Subcutaneous Drug Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Subcutaneous Drug Delivery Devices Market, by Region, 2018-2027 (USD Billion)
1.2.2. Subcutaneous Drug Delivery Devices Market, by Product, 2018-2027 (USD Billion)
1.2.3. Subcutaneous Drug Delivery Devices Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Subcutaneous Drug Delivery Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Subcutaneous Drug Delivery Devices Market Dynamics
3.1. Subcutaneous Drug Delivery Devices Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Subcutaneous Drug Delivery Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Subcutaneous Drug Delivery Devices Market, by Product
5.1. Market Snapshot
5.2. Global Subcutaneous Drug Delivery Devices Market by Product, Performance – Potential Analysis
5.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis
5.4.1. Prefilled Syringes
5.4.2. Pen Injectors
5.4.3. Auto Injectors
5.4.4. Wearable Injectors
5.4.5. Needle-Free Injectors
Chapter 6. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Subcutaneous Drug Delivery Devices Market by Distribution Channel, Performance – Potential Analysis
6.3. Global Subcutaneous Drug Delivery Devices Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
6.4. Subcutaneous Drug Delivery Devices Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
Chapter 7. Global Subcutaneous Drug Delivery Devices Market, Regional Analysis
7.1. Subcutaneous Drug Delivery Devices Market, Regional Market Snapshot
7.2. North America Subcutaneous Drug Delivery Devices Market
7.2.1. U.S. Subcutaneous Drug Delivery Devices Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Subcutaneous Drug Delivery Devices Market
7.3. Europe Subcutaneous Drug Delivery Devices Market Snapshot
7.3.1. U.K. Subcutaneous Drug Delivery Devices Market
7.3.2. Germany Subcutaneous Drug Delivery Devices Market
7.3.3. France Subcutaneous Drug Delivery Devices Market
7.3.4. Spain Subcutaneous Drug Delivery Devices Market
7.3.5. Italy Subcutaneous Drug Delivery Devices Market
7.3.6. Rest of Europe Subcutaneous Drug Delivery Devices Market
7.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market Snapshot
7.4.1. China Subcutaneous Drug Delivery Devices Market
7.4.2. India Subcutaneous Drug Delivery Devices Market
7.4.3. Japan Subcutaneous Drug Delivery Devices Market
7.4.4. Australia Subcutaneous Drug Delivery Devices Market
7.4.5. South Korea Subcutaneous Drug Delivery Devices Market
7.4.6. Rest of Asia Pacific Subcutaneous Drug Delivery Devices Market
7.5. Latin America Subcutaneous Drug Delivery Devices Market Snapshot
7.5.1. Brazil Subcutaneous Drug Delivery Devices Market
7.5.2. Mexico Subcutaneous Drug Delivery Devices Market
7.6. Rest of The World Subcutaneous Drug Delivery Devices Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Medtronic plc
8.2.3. Ypsomed AG
8.2.4. Elcam Medical Group
8.2.5. Novo Nordisk A/S
8.2.6. Insulet Corporation
8.2.7. Becton, Dickinson, and Company
8.2.8. West Pharmaceutical Services, Inc.
8.2.9. PharmaJet, Inc.
8.2.10. Unilife Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. Global Subcutaneous Drug Delivery Devices market, report scope
TABLE 2. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by Product 2017-2027 (USD Billion)
TABLE 4. Global Subcutaneous Drug Delivery Devices market estimates & forecasts by Distribution Channel 2017-2027 (USD Billion)
TABLE 5. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Subcutaneous Drug Delivery Devices market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Subcutaneous Drug Delivery Devices market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. U.S. Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 25. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. UK Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 28. UK Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 31. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. France Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 34. France Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 37. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 40. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 43. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. China Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 46. China Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. India Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 49. India Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 52. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 55. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 58. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 61. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 64. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 67. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 70. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 73. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Subcutaneous Drug Delivery Devices market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. List of secondary sources, used in the study of global Subcutaneous Drug Delivery Devices market
TABLE 76. List of primary sources, used in the study of global Subcutaneous Drug Delivery Devices market
TABLE 77. Years considered for the study
TABLE 78. Exchange rates considered
FIG 1. Global Subcutaneous Drug Delivery Devices market, research methodology
FIG 2. Global Subcutaneous Drug Delivery Devices market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Subcutaneous Drug Delivery Devices market, key trends 2019
FIG 5. Global Subcutaneous Drug Delivery Devices market, growth prospects 2020-2027
FIG 6. Global Subcutaneous Drug Delivery Devices market, porters 5 force Model
FIG 7. Global Subcutaneous Drug Delivery Devices market, pest analysis
FIG 8. Global Subcutaneous Drug Delivery Devices market, value chain analysis
FIG 9. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Subcutaneous Drug Delivery Devices market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Subcutaneous Drug Delivery Devices market, regional snapshot 2017 & 2027
FIG 18. North America Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)
FIG 19. Europe Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)
FIG 21. Latin America Subcutaneous Drug Delivery Devices market 2017 & 2027 (USD Billion)
FIG 22. Global Subcutaneous Drug Delivery Devices market, company market share analysis (2019)
Gerresheimer AG
Medtronic plc
Ypsomed AG
Elcam Medical Group
Novo Nordisk A/S
Insulet Corporation
Becton, Dickinson, and Company
West Pharmaceutical Services, Inc.
PharmaJet, Inc.
Unilife Corporation

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.